Sandoz Group AG Share Price

Equities

SDZ

CH1243598427

Pharmaceuticals

Market Closed - Swiss Exchange 16:30:28 26/06/2024 BST 5-day change 1st Jan Change
32.27 CHF -0.03% Intraday chart for Sandoz Group AG -1.53% +19.25%

Financials

Sales 2024 * 10.29B 9.24B 815B Sales 2025 * 10.96B 9.83B 868B Capitalization 15.51B 13.92B 1,229B
Net income 2024 * 710M 637M 56.26B Net income 2025 * 974M 874M 77.17B EV / Sales 2024 * 1.81 x
Net Debt 2024 * 3.12B 2.8B 247B Net Debt 2025 * 2.73B 2.45B 216B EV / Sales 2025 * 1.66 x
P/E ratio 2024 *
22.2 x
P/E ratio 2025 *
15.9 x
Employees 22,633
Yield 2024 *
1.76%
Yield 2025 *
2.27%
Free-Float 91.29%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.48%
1 week-1.53%
Current month+0.66%
1 month-0.74%
3 months+20.41%
6 months+20.10%
Current year+19.25%
More quotes
1 week
31.71
Extreme 31.71
33.07
1 month
30.76
Extreme 30.76
33.11
Current year
25.33
Extreme 25.33
33.11
1 year
22.70
Extreme 22.7
33.11
3 years
22.70
Extreme 22.7
33.11
5 years
22.70
Extreme 22.7
33.11
10 years
22.70
Extreme 22.7
33.11
More quotes
Date Price Change Volume
26/06/24 32.27 -0.03% 922 199
25/06/24 32.28 +0.47% 888,845
24/06/24 32.13 -1.98% 1,165,037
21/06/24 32.78 -0.49% 2,122,455
20/06/24 32.94 +0.52% 950,207

Delayed Quote Swiss Exchange, June 26, 2024 at 04:30 pm

More quotes
Sandoz Group AG is a Switzerland based company which is active in healthcare technology industry. The Company operates in two businesses, Generics and Biosimilars. Generics business develops, manufacture and market active ingredients and finished dosage forms of small molecule pharmaceuticals, finished dosage forms of anti-infectives and active pharmaceutical ingredients and intermediates. Biosimilars business develops, manufacture and market protein-based and other biological products which are similar to another already approved biological medicines. Company’s product portfolio comprising Generics and Biosimilars covers all therapeutic areas for patient treatment such as cardiovascular, central nervous system, oncology, anti-infectives, pain and respiratory. The Company serves customers worldwide.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
36.09 USD
Average target price
40.41 USD
Spread / Average Target
+11.96%
Consensus

Quarterly revenue - Rate of surprise